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Abstract
Despite the well-known role of satellite cells in skeletal muscle plasticity, the
effect of spinal cord injury on their function in humans remains unknown.
We determined whether spinal cord injury affects the intrinsic ability of satel-
lite cells to differentiate and produce metabolically healthy myotubes. We
obtained vastus lateralis biopsies from eight spinal cord-injured and six able-
bodied individuals. Satellite cells were isolated, grown and differentiated
in vitro. Gene expression was measured by quantitative PCR. Abundance of
differentiation markers and regulatory proteins was determined by Western
blotting. Protein synthesis and fatty acid oxidation were measured by radioac-
tive tracer-based assays. Activated satellite cells (myoblasts) and differentiated
myotubes derived from skeletal muscle of able-bodied and spinal cord-injured
individuals expressed similar (P > 0.05) mRNA levels of myogenic regulatory
factors. Myogenic differentiation factor 1 expression was higher in myoblasts
from spinal cord-injured individuals. Desmin and myogenin protein content
was increased upon differentiation in both groups, while myotubes from
spinal cord-injured individuals contained more type I and II myosin heavy
chain. Phosphorylated and total protein levels of Akt-mechanistic target of
rapamycin and forkhead box protein O signalling axes and protein synthesis
rate in myotubes were similar (P > 0.05) between groups. Additionally, fatty
acid oxidation of myotubes from spinal cord-injured individuals was
unchanged (P > 0.05) compared to able-bodied controls. Our results indicate
that the intrinsic differentiation capacity of satellite cells and metabolic char-
acteristics of myotubes are preserved following spinal cord injury. This may
inform potential interventions targeting satellite cell activation to alleviate
skeletal muscle atrophy.
Introduction
Traumatic spinal cord injury has a prevalence of between
250 and 906 cases per million in developed countries
(Singh et al. 2014), and leads to severe physical and psy-
chosocial consequences. It is characterized by varying
degrees of motor, sensory and autonomic neurological
deficits below the level of injury, affecting most bodily
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systems (Binder 2013). Decentralization of skeletal muscle
from the nervous system causes inactivity and marked
atrophy, with a decrease of both single fiber and whole
muscle cross sectional area (Castro et al. 1999; Gorgey
and Dudley 2007). The decrease in muscle mass is attrib-
uted to an imbalance between protein synthesis and
degradation, with associated changes in the protein kinase
B (Akt) – mechanistic target of rapamycin (mTOR) sig-
nalling axis, and activity of the forkhead box protein O
(FoxO) transcription factors and their targets, respectively
(Jackman and Kandarian 2004; Dreyer et al. 2008; Leger
et al. 2009). Atrophy reduces the size of all fibers and
shifts the fiber type composition from type I oxidative
fibers to predominantly type IIx glycolytic fibers (Lotta
et al. 1991; Aksnes et al. 1996; Castro et al. 1999; Kos-
tovski et al. 2013). Along with morphological changes,
spinal cord injury reduces the fatty acid oxidation capac-
ity of skeletal muscle (Wang et al. 1999; Kjaer et al. 2001;
Long et al. 2011; McCully et al. 2011). Moreover, the
reduced muscle mass diminishes peripheral glucose dis-
posal (Aksnes et al. 1996). Impairments in both lipid and
glucose metabolism ultimately increase the risk of non-
communicable diseases such as type 2 diabetes and car-
diovascular disease (Cragg et al. 2013a,b).
Satellite cells are located between the sarcolemma and
the basement membrane of the muscle fibers (Mauro
1961). These cells play an integral role in muscle plasticity
and regeneration through self-renewal and fusion into the
existing fibers (Schiaffino et al. 1976; Collins et al. 2005;
Bruusgaard et al. 2010; Lepper et al. 2011). Paired box
protein 7 (Pax7) positive satellite cells express myogenic
regulatory transcription factors, which show commitment
to the myogenic lineage (e.g., myogenic factor 5 – Myf5
and myogenic differentiation factor 1 – Myod1) and pas-
sage into terminal differentiation (e.g. myogenin)
(Almeida et al. 2016).
Individuals with spinal cord injury have a reduced
number of satellite cells per skeletal muscle fiber (Verdijk
et al. 2012). It is yet unclear whether spinal cord injury
affects the differentiation capacity of human skeletal mus-
cle satellite cells. Altered function of satellite cells has
been indicated by animal models. Spinal cord transection
and contusion in rats lead to satellite cell activation
(Dupont-Versteegden et al. 1999; Jayaraman et al. 2013).
However, the differentiation of satellite cells may be lack-
ing, as the myonuclear number continues to decrease in
these animals in spite of satellite cell activation (Dupont-
Versteegden et al. 1999). Several types of skeletal muscle
atrophy, with an underlying neurological mechanism, are
accompanied with abnormal satellite cell differentiation.
Denervation of rat skeletal muscle leads to formation of
new myotubes with defective contractile machinery (Car-
raro et al. 2015). Skeletal muscle satellite cells from
individuals with amyotrophic lateral sclerosis have
reduced differentiation capacity and form myotubes with
abnormal morphology (Pradat et al. 2011; Scaramozza
et al. 2014). However, whether skeletal muscle satellite cell
differentiation is affected by spinal cord injury in humans
remains unknown. As satellite cells play a role in regulat-
ing skeletal muscle mass and are responsive to exercise
stimuli (Bruusgaard et al. 2010), their ability to differenti-
ate is of importance in efforts to maintain skeletal muscle
mass following spinal cord injury.
Here, we determined the effect of spinal cord injury on
the intrinsic ability of satellite cells to differentiate. Addi-
tionally, we assessed the metabolic properties of cultured
myotubes to determine whether changes seen in vivo in
skeletal muscle after spinal cord injury are reflected in
satellite cell-derived myotubes in vitro. Myotubes differ-
entiated from satellite cells in vitro retain characteristics
of the donor skeletal muscle in several metabolic and
neurological conditions (Bouzakri et al. 2004; Pradat
et al. 2011; Boyle et al. 2012; Green et al. 2011, 2013;
Jiang et al. 2013; Scaramozza et al. 2014). Thus, primary
human skeletal muscle cultures have provided meaningful
insight into satellite cell function in muscle disorders.
Materials and Methods
Study participants
Fourteen individuals were studied, including eight men
with a longstanding (more than 1 year) spinal cord injury
currently undergoing routine follow-ups at Sunnaas reha-
bilitation hospital (Oslo, Norway), and six age-matched
able-bodied controls. Participants with spinal cord injury
received anticoagulant (clexane or equivalent) therapy
during the first 3–6 months after injury as well as spas-
molytic therapy (baclofen or equivalent). They did not
receive any corticosteroid treatment. Six men with no his-
tory of smoking, nonathletes, with no current use of med-
ications were recruited as able-bodied controls. Neither
spinal cord-injured nor able-bodied participants had any
known malignant, systemic or musculoskeletal disease,
nor an intercurrent infection. Participant characteristics
are shown in Table 1. The study was conducted according
to the ethical principles expressed in the declaration of
Helsinki (World Medical, A, 2013). All participants gave
their written informed consent and the study was
approved by the Regional Committee for Medical and
Health Research Ethics at Helse Sør-Øst Trust, Norway.
Skeletal muscle biopsy procedure
Participants were instructed to abstain from physical
activity the day before the biopsy. Skeletal muscle samples
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were obtained by either a semi-open or by an open
biopsy procedure (Henriksson 1979; Berman et al. 1985)
from the mid portion of vastus lateralis of the quadriceps
femoris muscle under local anesthesia (Lidocaine
5 mg mL1). A single piece of skeletal muscle (50–
100 mg) was obtained by either procedure and immedi-
ately transferred to ice cold phosphate buffered saline
(PBS) supplemented with 1% PenStrep (100 UI mL1
penicillin and 100 lg mL1 streptomycin) and kept on
ice.
Satellite cell isolation and culture of
primary skeletal muscle cells
Satellite cells were isolated from skeletal muscle samples
and cultured as previously described (Mudry et al. 2017).
Satellite cells were extracted using a collagenase solution;
attachment of nonsatellite cells was allowed for 1 h, after
which the supernatant containing satellite cells was col-
lected. Cells proliferated at 37°C and 7.5% CO2 in growth
medium (20% fetal bovine serum – FBS). Differentiation
was induced at ~80% confluence, using fusion medium
(100 lg mL1 apo-transferrin and 0.286 IU mL1 insu-
lin) for 4 days. Experiments were performed on differen-
tiated myotubes after an additional 4 days in post-fusion
medium (2% FBS). For assessment of differentiation cells
were harvested prior to (myoblasts), and 8 days after
(myotubes) the induction of differentiation.
Immunohistochemistry of primary skeletal
muscle cell cultures
Immunohistochemistry was performed as previously
described (Sjogren et al. 2015). Myoblasts and myotubes
were fixed in 4% paraformaldehyde in PBS for 15 min at
room temperature. Desmin and Ki67 were detected by
indirect immunofluorescence using primary antibodies
against desmin (#15200 Abcam, Cambridge, U.K.) at a
concentration of 1:500 and against Ki67 (#9449 Cell Sig-
naling, Danvers, MA) at a concentration of 1:800. Sec-
ondary antibodies used (5 lg mL1) were Alexa Fluor
488 (#A-11008, Invitrogen, Carlsbad, CA) and Alexa
Fluor 594 (#A-11005, Invitrogen). Nuclei were stained by
4,6-diamidino-2-phenylindole (DAPI) (#D1306, Molecu-
lar Probes, Eugene, OR) according to the manufacturer’s
instructions.
RNA isolation, cDNA synthesis and qPCR
Cells were harvested in TRIzol (#15596-018, Life Tech-
nologies, Carlsbad, CA) and RNA was isolated according
to the manufacturer’s instructions. RNA concentration
was determined by Nanodrop ND-1000 (Thermo Fischer
Scientific) and 1000 ng was loaded as template for cDNA
synthesis, which was performed using the high-capacity
cDNA reverse transcriptase kit (#4368814, Applied Biosys-
tems, Foster City, CA). Quantitative PCR (qPCR) was
performed using Fast SYBR Green Master Mix (#4385612,
Applied Biosystems) and Ct values were determined using
StepOne software v2.1 (Applied Biosystems). The results
were normalized to the geometric mean of two controls
genes, TATA-binding protein (TBP) and 60S acidic ribo-
somal protein P0 (RPLP0), and the expression calculated
by the ΔCt method. Primers used for the reactions were
designed to exon to exon junctions of the targeted genes.
Sequences of used primers are listed in Table 2. Each
assay was accompanied by a melt curve step, which have
shown a single clear peak for each set of primers.
SDS-PAGE and Western blot
Cells were harvested in ice cold lysis buffer (20 mmol L1
Tris-HCl pH 7.8) containing protease and phosphatase
inhibitors (#539131, Protease Inhibitor Coctail Set I –
Calbiochem, Merck Millipore, Billerica, MA; 1 mmol L1
PMSF; 0.5 mmol L1 Na3VO4). Protein concentration
was determined using Pierce BCA protein assay kit
(#23225, Thermo Fischer Scientific). Equal amounts of
protein were diluted in Laemmli buffer. Sodiumdodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
was performed as previously described (Sjogren et al.
2015), using Criterion XT Bis-Tris 4–12% precast gels
(#3450124, BioRad, Hercules, CA). Protein was trans-
ferred to an Immobilion-P polyvinylidene fluoride
(PVDF) membrane (#IPVH00010, Merck Millipore). Pon-
ceau staining was performed and the results are normal-
ized to the total amount of protein per lane. Western
blotting was performed using primary antibodies over-
night, at a 1:1000 concentration in tris-buffered saline
Table 1. Participant characteristics.
Age years
(range)
BMI (kg m2;
mean  SEM)
Able-bodied
participants (n = 6)
42 (33; 54) 22  1
Spinal cord-injured
participants (n = 8)
52 (26; 71) 26  21
Level of injury (n) Motor deficiency Time since injury (years)
C7 (2) Complete 11; 4
C7 Incomplete 8
Th4 Complete 34
Th5 Complete 20
Th12 (3) Incomplete 6; 5; 4
1P = 0.06 for BMI (able-bodied vs. spinal cord-injured).
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(TBS) containing 0.1% bovine serum albumin (BSA) and
0.1% NaN3. The antibodies used are listed in Table 3.
Species-appropriate horseradish peroxidase conjugated
secondary antibodies were used at a concentration of
1:25,000 in 5% milk in TBS-Tween. Proteins were visual-
ized by chemiluminescence (#RPN2232 ECL and
#RPN2235 ECL select Western blotting detection reagent
– GE Healthcare, Little Chalfont, U.K.) and the quantifi-
cation was performed by ImageLab software v. 5.2.1
(BioRad).
[14C]Phenylalanine incorporation into
protein
Fully differentiated myotubes were incubated in Dulbec-
co’s Modified Eagle Medium (DMEM) (1 g L1 glucose)
with 425 lmol L1 phenylalanine and 0.4 lCi mL1 of
[14C] phenylalanine (#NEC284E050UC, Perkin Elmer,
Waltham, MA) for 6 h at 37°C and 7.5% CO2. The cells
were then washed in PBS and lysed in 0.03% SDS for 1 h
at room temperature. The total amount of protein per
well was determined by the Pierce BCA protein assay kit
(#23225, Thermo Fischer Scientific). Protein from the cell
lysates was precipitated in 50% Trichloracetic acid with
1% BSA, overnight at 20°C, followed by centrifugation.
The protein pellet was then washed in acetone, dissolved
in 0.5 mol L1 NaOH and the amount of [14C] deter-
mined by scintillation counting (WinSpectral 1414 Liquid
Scintillation Counter; Wallac, Turku, Finland). Counts
per minute were normalized to the total amount of pro-
tein per well, and the amount of phenylalanine incorpo-
rated into protein is presented as pmol mg1 h1.
[3H] Palmitic acid oxidation assay
[3H] Palmitic acid oxidation was measured by produc-
tion of [3H] labeled water as previously described (Rune
et al. 2009). Differentiated myotubes were incubated for
6 h in DMEM (1 g L1 glucose) with 1 mCi mL1 [3H]
palmitic acid (#NET043005MC, Perkin Elmer),
25 lmol L1 palmitic acid and 0.02% fatty acid free
BSA. The collected medium was incubated in a charcoal
slurry (0.1 g activated charcoal per 1 mL 0.02 mol L1
Tris-HCl at pH 7.5), subjected to centrifugation, and the
supernatant was collected for scintillation counting
(WinSpectral 1414 Liquid Scintillation Counter; Wallac).
Cells were lysed in 0.03% SDS and the protein concen-
tration was determined using a commercially available
Bradford protein assay kit (#5000006, BioRad). Results
were normalized to the total protein amount per well
and the oxidation rate of palmitic acid is presented as
pmol mg1 h1.
Statistical analysis
Statistical significance of differences in gene expression
and protein content in myoblasts and myotubes from
spinal cord-injured and able-bodied individuals were
determined by a two-way ANOVA, followed by the
Sidak’s corrected multiple comparison test (Figs. 1, 2).
Differences between myotubes of the two groups were
determined by the Mann–Whitney test (Figs. 3, 4, 5). P
values below 0.05 were considered as statistically signifi-
cant, while values below 0.1 are reported as trends. Statis-
tical analyses were performed, using the GraphPad Prism
v. 7.01 (GraphPad, La Jolla, CA).
Results
Differentiation of skeletal muscle satellite
cells
To determine the differentiation capacity of skeletal
muscle satellite cells, activated satellite cells (myoblasts)
were differentiated into myotubes. We assessed myotube
formation by immunohistochemistry for differentiation
(desmin) and proliferation (Ki67) markers and nuclear
staining with DAPI. Qualitative assessment of
Table 2. Sequences of primers used for qPCR.
Target gene Forward primer Reverse primer
TBP AGTTCTGGGATTGTACCGCA TATATTCGGCGTTTCGGGCA
RPLP0 TGGAGAAACTGCTGCCTCAT GATTTCAATGGTGCCCCTGG
Pax7 GAGGACCAAGCTGACAGAGG CTGGCAGAAGGTGGTTGAA
Myf5 CCACCTCCAACTGCTCTGAT GCAATCCAAGCTGGATAAGG
Myod1 AGCACTACAGCGGCGACT GCGCCTCGTTGTAGTAGGC
Myf6 GGATCAGCAGGAGAAGATGC CCTGGAATGATCGGAAACAC
Myogenin GCTCAGCTCCCTCAACCA GCTGTGAGAGCTGCATTCG
Desmin CTGGAGCGCAGAATTGAATC GGCAGTGAGGTCTGGCTTAG
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immunohistochemistry images has shown that, upon dif-
ferentiation, myoblasts from both spinal cord-injured and
able-bodied individuals fused and formed multinucleated
myotubes with an abundance of desmin and depletion of
Ki67 positive nuclei (Fig. 1A).
Western blot was used to assess protein levels of differ-
entiation markers of myoblasts and myotubes. Differenti-
ation increased (P < 0.05) cellular desmin, myogenin and
both type I and type II myosin heavy chain (MHC I and
II; Fig. 1B and C, respectively). Myotubes from spinal
cord-injured and able-bodied individuals had similar
(P > 0.05) levels of desmin and myogenin. Myotubes
from spinal cord-injured individuals displayed higher
(P < 0.05) protein abundance of MHC II, whereas MHC
I tended (P = 0.06) to be increased (Fig. 1B and C).
We next determined whether spinal cord injury affects
the transcriptional regulation of differentiation by assess-
ing the expression of myogenic regulatory factors in
myoblasts and myotubes from spinal cord-injured and
able-bodied individuals. The expression of Pax7, Myf5,
Myod1 and myogenic factor 6 (Myf6) decreased
(P < 0.05) throughout differentiation (Fig. 2A–D). Con-
versely, the expression of myogenin and desmin was
increased (P < 0.05) in myotubes compared to myoblasts
(Fig. 2E and F). Expression of Pax7, Myf5, Myf6, myo-
genin and desmin was similar (P > 0.05) in myoblasts,
as well as in myotubes from the spinal cord-injured and
able-bodied individuals (Fig. 2A, B and D–F; P > 0.05).
Expression of Myod1 was higher (P < 0.05) in myoblasts
from spinal cord-injured individuals compared to able-
bodied controls (Fig. 2C).
Protein synthesis in differentiated
myotubes
To determine whether myotubes from spinal cord-injured
individuals have an altered capacity for protein synthesis
we measured incorporation of [14C]-labeled phenylalanine
into protein. The incorporation of radiolabeled tracer into
protein was similar (P > 0.05) between myotubes from
spinal cord-injured and able-bodied individuals (Fig. 3A).
We found similar (P > 0.05) levels of phosphorylated
Akt(Ser473) and (Thr308), mTOR(Ser2448), 4E binding protein
1 (4EBP1)(Thr37/46), ribosomal protein S6 (S6)(Ser235/236),
and the corresponding total protein content in spinal
cord-injured and able-bodied individuals (Fig. 3B and C).
Similarly, content of regulatory-associated protein of
mTOR (raptor) was not different (P > 0.05) between
myotubes from spinal cord-injured and able-bodied indi-
viduals (Fig. 3B and C).
Protein degradation signalling in
differentiated myotubes
We used Western blot analysis to investigate pathways reg-
ulating protein degradation. Phosphorylated FoxO1(Ser256)
and FoxO3a(Ser253), as well as the total abundance of
FoxO3a were similar (Fig. 4A and B; P > 0.05) between
spinal cord-injured and able-bodied individuals. Total
protein content of FoxO1 tended to be decreased (Fig. 4A
and B; P = 0.06) in myotubes from spinal cord-injured
compared to able-bodied individuals. Protein levels of the
FoxO transcriptional targets including ubiquitin-binding
protein p62 (p62), microtubule-associated protein 1 light
chain 3 (LC3) I and II, and muscle atrophy F-box
(MAFbx) were unchanged (Fig. 4A and B; P > 0.05).
Similarly, protein abundance of the proteasomal 20Sa
catalytic subunit was comparable between myotubes from
spinal cord-injured and able-bodied individuals (Fig. 4A
and B; P > 0.05).
Table 3. Primary antibodies used for Western blot.
Antigen
Molecular
weight (kDa)
Product number
and supplier
Desmin 55 #15200 Abcam, Cambridge,
U.K.
Myogenin 34 #12732 Santa Cruz, Dallas, TX
MHC II (Myh1/2) 225 #53088 Santa Cruz
MHC I (Myh7) 225 #A4.840 DSHB, Iowa City, IA
pAkt(Ser473) 60 #4060 Cell Signaling Danvers,
MA
pAkt(Thr308) 60 #4056 Cell Signaling
Akt 60 #9272 Cell Signaling
pmTOR(Ser2448) 289 #600-401-422 Rockland,
Pottstown, PA
mTOR 289 #2983 Cell Signaling
Raptor 150 #2280 Cell Signaling
p4EBP1(Thr37/46) 20 #2855 Cell Signaling
4EBP1 20 #9452 Cell Signaling
pS6(Ser235/236) 32 #2211 Cell Signaling
S6 32 #2317 Cell Signaling
pFoxO1(Ser256) 78 #9461 Cell Signaling
FoxO1 78 #12161 Abcam
pFoxO3a(Ser253) 97 #13129 Cell Signaling
FoxO3a 97 #47409 Abcam
LC3 16/18 #L8918 Sigma Aldrich,
St. Louis, MO
p62 62 # P0067 Sigma Aldrich
MAFbx 35 #166806 Santa Cruz
Pan 20Sa 30–32 #22674 Abcam
pACC(Ser222) 280 #3661 Cell Signaling
ACC 280 #3676 Cell Signaling
MHC, myosin heavy chain; mTOR, mechanistic target of rapamy-
cin; 4EBP1, 4E binding protein 1; FoxO, forkhead box protein O;
LC, light chain; MAFbx, muscle atrophy F-box; ACC, acetyl-CoA
carboxylase.
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Figure 1. Differentiation of skeletal muscle satellite cells. (A) Representative images of immunohistochemistry for Ki67 and desmin, as well as
DAPI staining of the nuclei and an overlay of the three signals. (B) Protein content of muscle-specific differentiation markers (desmin, myogenin,
MHC I and MHC II) in myoblasts and myotubes from spinal cord-injured (gray bars) and able-bodied (white bars) individuals. Bars represent
mean  SD and individual data points are overlaid. n = 6–8; Two-way ANOVA: # – overall effect of differentiation (P < 0.05); * – Sidak’s post
hoc comparison (P < 0.05). (C) Representative Western blot images. DAPI, 4,6-diamidino-2-phenylindole; MHC, myosin heavy chain.
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Fatty acid oxidation in differentiated
myotubes
To determine the oxidative capacity of myotubes derived
from satellite cells of spinal cord-injured individuals, we
measured palmitic acid oxidation by production of [3H]-
labeled water from [3H]-labeled palmitic acid. The oxida-
tion of palmitic acid was similar between satellite cells of
spinal cord-injured and able-bodied individuals
(P > 0.05; Fig. 5A). Moreover, total and phosphorylated
protein content of acetyl-CoA carboxylase (ACC)(Ser222)
was similar (P > 0.05) between skeletal muscle satellite
*
M yo b la s ts M yo tu b e s
0
5
1 0
1 5 #
M yo b la s ts M yo tu b e s
0
1
2
3
4 #
M yo b la s ts M yo tu b e s
0
2
4
6 #
M yo b la s ts M yo tu b e s
0
5
1 0
1 5
M
y
f6
e
x
p
re
s
s
io
n
(f
o
ld
o
f
A
B
m
y
o
t u
b
e
s
) #
M yo b la s ts M yo tu b e s
0
5
1 0
1 5
2 0
2 5
M
y
f5
e
x
p
re
s
s
io
n
(f
o
ld
o
f
A
B
m
y
o
tu
b
e
s
) #
M yo b la s ts M yo tu b e s
0
5
1 0
1 5
P
a
x
7
e
x
p
re
s
s
io
n
(f
o
ld
o
f
A
B
m
y
o
tu
b
e
s
) #
(B)(A)
(C) (D)
(E) (F)
A b le - b o d ie d
S p in a l c o rd - in ju re d
M
y
o
d
1
e
x
p
re
s
s
i o
n
(f
o
ld
o
f
A
B
m
y
o
tu
b
e
s
)
M
y
o
g
e
n
in
e
x
p
re
s
s
io
n
(f
o
ld
o
f
A
B
m
y
o
tu
b
e
s
)
D
e
s
m
in
e
x
p
re
s
s
io
n
( f
o
ld
o
f
A
B
m
y
o
tu
b
e
s
)
Figure 2. Regulation of differentiation of skeletal muscle satellite cells. Expression of myogenic regulatory factors (A) Pax7, (B) Myf5, (C)
Myod1, (D) Myf6, (E) myogenin, and (F) desmin, in myoblasts and myotubes from spinal cord-injured (gray bars) and able-bodied (white bars)
individuals. Bars represent mean  SD and individual data points are overlaid. n = 6–8; Two-way ANOVA: # – overall effect of differentiation
(P < 0.05); * – Sidak’s post hoc comparison (P < 0.05).
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cells of spinal cord-injured and able-bodied individuals
(Fig. 5B and C).
Discussion
Satellite cells play an important role in skeletal muscle
regeneration and plasticity (Schiaffino et al. 1976; Collins
et al. 2005; Bruusgaard et al. 2010; Lepper et al. 2011).
However, little is known regarding their differentiation
capacity in human skeletal muscle following a spinal cord
injury. We assessed the myogenic programming of satel-
lite cells obtained from skeletal muscle of spinal cord-
injured individuals. We provide evidence that skeletal
muscle satellite cells retain their capacity to differentiate
after spinal cord injury. Moreover, once differentiated the
myotubes show comparable metabolic characteristics to
those from able-bodied individuals. Collectively, our data
indicates that the intrinsic myogenic programming of
skeletal muscle satellite cells is retained in individuals with
spinal cord injury.
During satellite cell isolation, we attempted to filter out
nonsatellite cells by allowing their attachment, although a
formal assessment of purity was not performed. Our
study included spinal cord-injured participants after a
longstanding (>1 year) injury, a period when skeletal
muscle has undergone dramatic skeletal muscle atrophy
(Moore et al. 2015). We show that satellite cells do not
mirror such prominent changes when grown in vitro.
However, due to the relatively low number of participants
(n = 6–8), it is possible that more subtle changes exist
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Figure 3. Protein synthesis in differentiated myotubes. (A) Phenylanine incorporation into protein in myotubes from spinal cord-injured (gray
bars) and able-bodied (white bars) individuals. Bars represent mean  SD and individual data points are overlaid. (B) Phosphorylated and total
protein content of molecules in the Akt-mTOR signalling axis (pAkt(Ser473), pAkt(Thr308), total Akt, mTOR(Ser2448), total mTOR, Raptor,
p4EBP1(Ser37/46), total 4EBP, pS6(Ser235/236), total S6) in myotubes from spinal cord-injured (gray bars) and able-bodied (white bars) individuals.
Bars represent mean  SD and individual data points are overlaid. n = 6–8; Mann–Whitney test (significance P < 0.05). (C) Representative
Western blot images. mTOR, mechanistic target of rapamycin; 4EBP, 4E binding protein.
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which we are underpowered to detect. Finally, the spinal-
cord injury group consisted of participants with both
incomplete and complete spinal-cord injury, but none
were freely ambulating. However, we cannot rule out that
remaining motor activity or muscular spasms may influ-
ence satellite cell function.
We have shown that during differentiation, myoblasts
from spinal cord-injured individuals retain the capacity to
exit the cell cycle, as evidenced by the decrease of Ki67
nuclear localization through differentiation (Scholzen and
Gerdes 2000), and form multinucleated myotubes, with
levels of desmin similar to myotubes from able-bodied
controls. Additionally, protein abundance of muscle speci-
fic structural proteins (desmin and MHC) was increased
during differentiation in both cells from able-bodied and
spinal cord-injured individuals. Surprisingly, we found
the abundance of MHC I and MHC II was increased in
myotubes from spinal cord-injured versus able-bodied
individuals. Spinal cord injury is associated with a
decrease of MHC I and an increase of MHC II in skeletal
muscle in vivo, reflecting the change in fiber type-compo-
sition from type I to predominantly type II fibers (Lotta
et al. 1991; Castro et al. 1999; Kostovski et al. 2013). Our
findings of increased MHC II in differentiated myotubes
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Figure 4. Protein degradation signalling in differentiated myotubes. (A) Phosphorylated and total protein content of FoxO1(Ser256) and
FoxO3(Ser253) transcription factors, and their targets (LC3I, LC3II, p62, MAFbx), as well as the total protein levels of 20Sa proteosomal subunit in
myotubes from spinal cord-injured (gray bars) and able-bodied (white bars) individuals. Bars represent mean  SD and individual data points
are overlaid. n = 6–8; Mann–Whitney test (significance P < 0.05). (B) Representative Western blot images. FoxO, forkhead box protein O; LC,
light chain; MAFbx, muscle atrophy F-box.
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from spinal cord-injured individuals may indicate that
satellite cells retain a fiber-type memory. However, we
found a trend (P = 0.06) for increased MHC I in myo-
tubes from spinal cord-injured subjects, suggesting that
the alteration in the MHC content in myotubes may be
caused by different mechanisms. Nevertheless, the capac-
ity to increase skeletal muscle-specific structural proteins
during differentiation indicates that the differentiation
capacity in satellite cells from spinal cord-injured individ-
uals is preserved.
Pax7 and myogenic regulatory factors direct differentia-
tion (Almeida et al. 2016). In the early stages of differen-
tiation, commitment to the myogenic lineage is evident
by high expression of Myf5 and Myod1 (Almeida et al.
2016). Distinct populations of myoblasts express either
Myf5 or Myod1 upon activation, and these factors show
an overlapping role in differentiation (Rudnicki et al.
1993; Cooper et al. 1999). As myoblasts from spinal cord-
injured individuals had higher Myod1 expression com-
pared to those from able-bodied controls, a larger portion
of myoblasts from spinal cord-injured individuals may
belong to the Myod1 positive group. As differentiation
progresses, the terminal stages are characterized by
increased myogenin expression (Almeida et al. 2016). In
cells from both able-bodied and spinal cord-injured indi-
viduals, the expression of Pax7, Myf5 and Myod1
decreased through differentiation, while the expression of
myogenin increased through differentiation. These data
suggest that satellite cells from spinal cord-injured indi-
viduals are committed to the myogenic lineage, evidenced
by high Myf5 and Myod1 expression, and are able to
undergo terminal differentiation and increase myogenin
expression in myotubes. Thus, in addition to their differ-
entiation capacity, the regulation of differentiation in
satellite cells from spinal cord-injured individuals is pre-
served. In the current study, we have not determined the
proliferation capacity of satellite cells. As spinal cord
injury leads to their activation (Dupont-Versteegden et al.
1999; Jayaraman et al. 2013), this is a parameter of inter-
est, especially if inherent satellite cells are to be used to
combat muscle atrophy.
Loss of skeletal muscle mass is mainly attributed to an
imbalance between anabolic and catabolic protein meta-
bolism (Jackman and Kandarian 2004). Akt-mTOR sig-
nalling undergoes a coordinated decrease in skeletal
muscle of spinal cord-injured in vivo, indicating
decreased protein synthesis (Dreyer et al. 2008). Our find-
ings of unchanged protein abundance of the Akt-mTOR
signalling axis members and amino acid incorporation
into protein in myotubes directly contrast the in vivo
observations. We conclude that skeletal muscle satellite
cells after spinal cord injury retain their ability to produce
myotubes with a normal capacity for, and regulation of
protein synthesis.
With chronic spinal cord injury, FoxO transcriptional
activity and the expression of their downstream targets
involved in protein degradation are reduced (Leger et al.
2009; Milan et al. 2015). We reported a tendency
(P = 0.06) for reduced total FoxO1 protein in myotubes
from spinal cord-injured individuals, with no changes in
phosphorylated (inactive) levels of both FoxO1(Ser256) and
FoxO3a(Ser253), as well as the total protein content of
FoxO3a. The tendency of reduced FoxO1 total protein
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Figure 5. Oxidative capacity of differentiated myotubes. (A)
Palmitic acid oxidation in myotubes from spinal cord-injured (gray
bars) and able-bodied (white bars) individuals. Bars represent
mean  SD and individual data points are overlaid. (B) Protein
content of total and phosphorylated ACC(Ser222) in myotubes from
spinal cord-injured (gray bars) and able-bodied (white bars)
individuals. Bars represent mean  SD and individual data points
are overlaid. n = 6–8; Mann–Whitney test: (significance P < 0.05).
(C) Representative Western blot images. ACC, acetyl-CoA
carboxylase.
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content could indicate lower transcriptional activity.
However, as there were no changes in protein abundance
of FoxO transcriptional targets (p62, LC3I, LC3II and
MAFbx) (Milan et al. 2015) we conclude that in contrast
to the observations in skeletal muscle in vivo following
spinal cord injury, the FoxO transcriptional regulation of
protein degradation is unchanged in satellite cell-derived
myotubes in vitro.
Additionally, the comparable levels of p62, the ubiqui-
tin-binding autophagy cargo adapter, and LC3I and II,
the autophagosome-forming proteins, indicate similar
levels of macroautophagy between myotubes from spinal
cord-injured and able-bodied individuals (Mizushima and
Yoshimori 2007). Unchanged abundance of MAFbx, an
ubiquitin E3 ligase and pan20Sa proteasomal proteolytic
subunit in myotubes from spinal cord-injured individuals,
indicate stable levels of ubiquitination and proteosomal
degradation, respectively. Together, this could indicate
stable levels of protein degradation in myotubes from
spinal cord-injured individuals.
Skeletal muscle following spinal cord injury in vivo has
decreased b-oxidation, mirrored by reductions in free
fatty acid uptake, mitochondrial content and levels of
oxidative enzymes (Wang et al. 1999; Kjaer et al. 2001;
Long et al. 2011; McCully et al. 2011). Conversely, myo-
tubes from spinal cord-injured and able-bodied individu-
als were able to oxidize palmitic acid at a comparable
level. Total and phosphorylated protein content of
ACC(Ser222) were similar between the two groups, indicat-
ing stable regulation of the fatty acid metabolism. Thus,
in contrast to the reduced b-oxidation capacity in vivo,
skeletal muscle satellite cells from spinal cord-injured
individuals are able to produce myotubes with oxidative
capacity comparable to those from able-bodied controls.
Collectively, our data shows that the metabolic memory
of satellite cells is retained and they are able to produce
myotubes with normal protein and fatty acid metabolism,
in spite of the changes occurring in skeletal muscle
in vivo.
Previous animal studies indicate that spinal cord injury
leads to activation of satellite cells in the affected skeletal
muscle in vivo (Dupont-Versteegden et al. 1999; Jayara-
man et al. 2013). However, the terminal differentiation
of the cells may be lacking as the myonuclear number
continues to decrease (Dupont-Versteegden et al. 1999).
Other rat models of skeletal muscle atrophy, such as
lower motor neuron injury and denervation, also lead to
activation of satellite cells followed by inefficient differen-
tiation and underdeveloped myotubes, with deficient or
absent contractile machinery (Carraro et al. 2015).
Similar mechanisms, through activation and inefficient
differentiation, may be responsible for the reduction of
the satellite cell pool in the skeletal muscle of spinal
cord-injured individuals (Verdijk et al. 2012). However,
our data demonstrates that the intrinsic myogenic differ-
entiation capacity and the metabolic memory of satellite
cells from spinal cord-injured individuals are preserved
following spinal cord injury. Once extracted from the
skeletal muscle and grown in vitro, they differentiate and
produce myotubes that retain metabolic characteristics.
Thus, defects in satellite cell differentiation in skeletal
muscle of spinal cord-injured individuals may be
connected to the decentralized and atrophying skeletal
muscle “environment”, rather than a dysfunction in their
programming.
As satellite cells play a role in regulating skeletal mus-
cle mass (Bruusgaard et al. 2010), specific rehabilitative
interventions targeting their activation could be efficient
in reducing skeletal muscle atrophy after spinal cord
injury. Electrical stimulation coupled with exercise
improves the metabolic characteristics of skeletal muscle
in spinal cord-injured individuals (Hjeltnes et al. 1998;
Gorgey et al. 2017) and may be used as a potential acti-
vator of skeletal muscle regenerative machinery (Kern
and Carraro 2014). Different protocols of functional
electrical stimulation mimic different types of exercise
(Fornusek and Davis 2008; Bickel et al. 2015). Both
endurance and resistance training lead to an increase in
satellite cell number, while resistance training also leads
to an increase in myonuclear number (Bruusgaard et al.
2010; Kurosaka et al. 2012). In light of this, studies of
satellite cell response to different modalities and intensi-
ties of functional electrical stimulation could help design
specialized interventions for satellite cell activation. Fur-
ther studies analysing the response to electrical pulse
stimulation in vitro could reveal the full extent of func-
tionality of myotubes and inform these efforts in regard
to any underlying electrical stimulus intensity, frequency
and duration preference. Our findings may encourage
these future efforts, and highlight the prospect of inher-
ent satellite cell activation in attempts to prevent skeletal
muscle atrophy following spinal cord injury.
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